Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia

Figures & data

Table 1 Demographic Data Relating to Pregnant Women with RhD Sensitization

Characteristics	Frequency	%
Maternal Age in Years
32(25–38)	98	100
Parity
3(1–11)	98	100
PI	2	2
PII - IV	71	72.5
PV and above	25	25.5

Abbreviations: PI, Para one; PII – IV, Para two – four; PV, Para five.

Table 2 Perinatal Outcomes After Intrauterine Transfusion of Pregnant Women with RhD Sensitization

Perinatal Outcome	MCA PSV ≥1.5MOM
	Intrauterine Transfusion
	Yes		No
	Number	%	Number	%
Stillbirth	1	4.75	2	8.3
Live birth	19	90.5	20	83.4
END	1	4.75	2	8.3
Total	21	100	24	100

Abbreviations: MCA PSV, Middle Cerebral Artery Peak Systolic Velocity; MOM, Multiple of the Median; END, Early neonatal death.

Table 3 Perinatal Outcomes According to a Fetus with/Without Hydrops of Pregnant Women with Rh Sensitization

Perinatal Outcome	Without Hydrops		With Hydrops
	Number	%	Number	%
Stillbirth	1	1.1	2	33.3
Live birth	89	96.7	3	50
END	2	2.2	1	16.7
Total	92	100	6	100

Abbreviation: END, Early neonatal death.

Table 4 Performance of MCA PSV ≥1.5MOM in the Diagnosis of Moderate-Severe and Severe Fetal Anemia in Pregnant Women with RhD Sensitization

Characteristics	Frequency	%
Hb level at 1ˢͭ IUT:
Hb ≥ 2g/dl below normal for GA	6	28.6
Hb >7g/dl below normal for GA	11	52.4
Hb < 2g/dl below normal for GA	4	19
Hct level at birth:
Hct < 25%	3	14.3
Hct = 25–35%	15	71.4
Hct >35%	2	9.5
GA at 1st IUT
24–28+6weeks	2	9.5
29–32+6 weeks	13	61.9
33–35 weeks	6	28.6

Abbreviations: Hb, Hemoglobin; IUT, Intrauterine transfusion; GA, Gestational Age; Hct, Hematocrit.

Table 5 Neonatal Outcomes After Intrauterine Transfusion of Pregnant Women with RhD Sensitization

Neonatal Outcomes	Frequency	%
Admission to NICU	20	95.23
Phototherapy	20	95.23
Exchange transfusion: Yes	15	71.4
No	5	23.8
Simple Transfusion: Yes	4	19
No	16	76.2

Abbreviation: NICU, Neonatal Intensive Care Unit.